Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs1042713

Current Build 157

Released September 3, 2024

Organism
Homo sapiens
Position
chr5:148826877 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
G>A / G>C
Variation Type
SNV Single Nucleotide Variation
Frequency
A=0.3837109 (537556/1400940, GnomAD_exomes)
A=0.388003 (145748/375636, ALFA)
A=0.427421 (113134/264690, TOPMED) (+ 27 more)
A=0.427243 (63737/149182, GnomAD_genomes)
A=0.420360 (51009/121346, ExAC)
A=0.45942 (36148/78682, PAGE_STUDY)
A=0.49428 (38279/77444, 38KJPN)
A=0.42647 (10365/24304, PharmGKB)
G=0.4551 (3291/7232, Korea4K)
A=0.4758 (3047/6404, 1000G_30X)
A=0.4756 (2382/5008, 1000G)
A=0.3942 (1766/4480, Estonian)
A=0.3752 (1446/3854, ALSPAC)
A=0.3627 (1345/3708, TWINSUK)
A=0.4450 (1456/3272, PRJNA289433)
G=0.4621 (1353/2928, KOREAN)
A=0.4726 (985/2084, HGDP_Stanford)
A=0.4736 (896/1892, HapMap)
G=0.4634 (849/1832, Korea1K)
A=0.3783 (429/1134, Daghestan)
A=0.356 (355/998, GoNL)
G=0.462 (366/792, PRJEB37584)
G=0.441 (271/614, Vietnamese)
A=0.428 (257/600, NorthernSweden)
A=0.382 (204/534, MGP)
G=0.330 (134/406, SGDP_PRJ)
A=0.421 (128/304, FINRISK)
A=0.370 (80/216, Qatari)
A=0.32 (30/94, Ancient Sardinia)
G=0.39 (15/38, Siberian)
Clinical Significance
Reported in ClinVar
Gene : Consequence
ADRB2 : Missense Variant
Publications
221 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 375636 G=0.611997 A=0.388003 0.377482 0.153489 0.469029 16
European Sub 314598 G=0.625681 A=0.374319 0.392666 0.141304 0.46603 3
African Sub 16466 G=0.50455 A=0.49545 0.259201 0.250091 0.490708 2
African Others Sub 590 G=0.488 A=0.512 0.267797 0.291525 0.440678 3
African American Sub 15876 G=0.50517 A=0.49483 0.258881 0.248551 0.492567 1
Asian Sub 6938 G=0.4372 A=0.5628 0.192851 0.318536 0.488613 0
East Asian Sub 4980 G=0.4452 A=0.5548 0.202811 0.31245 0.484739 1
Other Asian Sub 1958 G=0.4168 A=0.5832 0.167518 0.334014 0.498468 0
Latin American 1 Sub 1474 G=0.5550 A=0.4450 0.317503 0.207598 0.474898 1
Latin American 2 Sub 7236 G=0.5629 A=0.4371 0.31592 0.19016 0.493919 0
South Asian Sub 5224 G=0.5532 A=0.4468 0.311256 0.204824 0.48392 1
Other Sub 23700 G=0.58768 A=0.41232 0.349283 0.173924 0.476793 2


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
gnomAD v4 - Exomes Global Study-wide 1400940 G=0.6162891 A=0.3837109
gnomAD v4 - Exomes European Sub 1165314 G=0.6322777 A=0.3677223
gnomAD v4 - Exomes South Asian Sub 86220 G=0.55146 A=0.44854
gnomAD v4 - Exomes American Sub 44724 G=0.56860 A=0.43140
gnomAD v4 - Exomes East Asian Sub 39700 G=0.47456 A=0.52544
gnomAD v4 - Exomes African Sub 33468 G=0.50636 A=0.49364
gnomAD v4 - Exomes Ashkenazi Jewish Sub 26134 G=0.55835 A=0.44165
gnomAD v4 - Exomes Middle Eastern sub 5380 G=0.5996 A=0.4004
Allele Frequency Aggregator Total Global 375636 G=0.611997 A=0.388003
Allele Frequency Aggregator European Sub 314598 G=0.625681 A=0.374319
Allele Frequency Aggregator Other Sub 23700 G=0.58768 A=0.41232
Allele Frequency Aggregator African Sub 16466 G=0.50455 A=0.49545
Allele Frequency Aggregator Latin American 2 Sub 7236 G=0.5629 A=0.4371
Allele Frequency Aggregator Asian Sub 6938 G=0.4372 A=0.5628
Allele Frequency Aggregator South Asian Sub 5224 G=0.5532 A=0.4468
Allele Frequency Aggregator Latin American 1 Sub 1474 G=0.5550 A=0.4450
TopMed Global Study-wide 264690 G=0.572579 A=0.427421
gnomAD v4 - Genomes Global Study-wide 149182 G=0.572757 A=0.427243
gnomAD v4 - Genomes European Sub 78588 G=0.61796 A=0.38204
gnomAD v4 - Genomes African Sub 41542 G=0.50655 A=0.49345
gnomAD v4 - Genomes American Sub 15306 G=0.56501 A=0.43499
gnomAD v4 - Genomes East Asian Sub 5154 G=0.4558 A=0.5442
gnomAD v4 - Genomes South Asian Sub 4828 G=0.5561 A=0.4439
gnomAD v4 - Genomes Ashkenazi Jewish Sub 3470 G=0.5700 A=0.4300
gnomAD v4 - Genomes Middle Eastern sub 294 G=0.605 A=0.395
ExAC Global Study-wide 121346 G=0.579640 A=0.420360
ExAC Europe Sub 73328 G=0.61319 A=0.38681
ExAC Asian Sub 25142 G=0.51241 A=0.48759
ExAC American Sub 11572 G=0.57968 A=0.42032
ExAC African Sub 10404 G=0.50673 A=0.49327
ExAC Other Sub 900 G=0.567 A=0.433
The PAGE Study Global Study-wide 78682 G=0.54058 A=0.45942
The PAGE Study AfricanAmerican Sub 32510 G=0.51701 A=0.48299
The PAGE Study Mexican Sub 10810 G=0.56549 A=0.43451
The PAGE Study Asian Sub 8318 G=0.5043 A=0.4957
The PAGE Study PuertoRican Sub 7916 G=0.5450 A=0.4550
The PAGE Study NativeHawaiian Sub 4524 G=0.6479 A=0.3521
The PAGE Study Cuban Sub 4228 G=0.5868 A=0.4132
The PAGE Study Dominican Sub 3828 G=0.5679 A=0.4321
The PAGE Study CentralAmerican Sub 2450 G=0.5531 A=0.4469
The PAGE Study SouthAmerican Sub 1982 G=0.5207 A=0.4793
The PAGE Study NativeAmerican Sub 1260 G=0.5397 A=0.4603
The PAGE Study SouthAsian Sub 856 G=0.527 A=0.473
38KJPN JAPANESE Study-wide 77444 G=0.50572 A=0.49428
PharmGKB Aggregated Global Study-wide 24304 G=0.57353 A=0.42647
PharmGKB Aggregated PA159673097 Sub 4926 G=0.5763 A=0.4237
PharmGKB Aggregated PA142093862 Sub 4412 G=0.5966 A=0.4034
PharmGKB Aggregated PA150735890 Sub 3700 G=0.5573 A=0.4427
PharmGKB Aggregated PA143081417 Sub 2538 G=0.5768 A=0.4232
PharmGKB Aggregated PA130771015 Sub 2108 G=0.5612 A=0.4388
PharmGKB Aggregated PA128523245 Sub 1912 G=0.5565 A=0.4435
PharmGKB Aggregated PA144488543 Sub 1164 G=0.5404 A=0.4596
PharmGKB Aggregated PA159666606 Sub 1076 G=0.5465 A=0.4535
PharmGKB Aggregated PA129185701 Sub 680 G=0.579 A=0.421
PharmGKB Aggregated PA130625709 Sub 594 G=0.616 A=0.384
PharmGKB Aggregated PA129947802 Sub 420 G=0.619 A=0.381
PharmGKB Aggregated PA152250230 Sub 314 G=0.615 A=0.385
PharmGKB Aggregated PA129965075 Sub 192 G=0.583 A=0.417
PharmGKB Aggregated PA134858392 Sub 178 G=0.545 A=0.455
PharmGKB Aggregated PA142648497 Sub 90 G=0.62 A=0.38
Korean Genome Project 4K KOREAN Study-wide 7232 G=0.4551 A=0.5449
1000Genomes_30X Global Study-wide 6404 G=0.5242 A=0.4758
1000Genomes_30X African Sub 1786 G=0.4798 A=0.5202
1000Genomes_30X Europe Sub 1266 G=0.6193 A=0.3807
1000Genomes_30X South Asian Sub 1202 G=0.5449 A=0.4551
1000Genomes_30X East Asian Sub 1170 G=0.4538 A=0.5462
1000Genomes_30X American Sub 980 G=0.541 A=0.459
1000Genomes Global Study-wide 5008 G=0.5244 A=0.4756
1000Genomes African Sub 1322 G=0.4796 A=0.5204
1000Genomes East Asian Sub 1008 G=0.4514 A=0.5486
1000Genomes Europe Sub 1006 G=0.6143 A=0.3857
1000Genomes South Asian Sub 978 G=0.554 A=0.446
1000Genomes American Sub 694 G=0.543 A=0.457
Genetic variation in the Estonian population Estonian Study-wide 4480 G=0.6058 A=0.3942
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 G=0.6248 A=0.3752
UK 10K study - Twins TWIN COHORT Study-wide 3708 G=0.6373 A=0.3627
MxGDAR/Encodat-PGx Global Study-wide 3272 G=0.5550 A=0.4450
MxGDAR/Encodat-PGx MxGDAR Sub 3272 G=0.5550 A=0.4450
KOREAN population from KRGDB KOREAN Study-wide 2928 G=0.4621 A=0.5379, C=0.0000
HGDP-CEPH-db Supplement 1 Global Study-wide 2084 G=0.5274 A=0.4726
HGDP-CEPH-db Supplement 1 Est_Asia Sub 470 G=0.509 A=0.491
HGDP-CEPH-db Supplement 1 Central_South_Asia Sub 414 G=0.539 A=0.461
HGDP-CEPH-db Supplement 1 Middle_Est Sub 350 G=0.569 A=0.431
HGDP-CEPH-db Supplement 1 Europe Sub 320 G=0.644 A=0.356
HGDP-CEPH-db Supplement 1 Africa Sub 242 G=0.554 A=0.446
HGDP-CEPH-db Supplement 1 America Sub 216 G=0.407 A=0.593
HGDP-CEPH-db Supplement 1 Oceania Sub 72 G=0.14 A=0.86
HapMap Global Study-wide 1892 G=0.5264 A=0.4736
HapMap American Sub 770 G=0.540 A=0.460
HapMap African Sub 692 G=0.478 A=0.522
HapMap Asian Sub 254 G=0.520 A=0.480
HapMap Europe Sub 176 G=0.665 A=0.335
Korean Genome Project KOREAN Study-wide 1832 G=0.4634 A=0.5366
Genome-wide autozygosity in Daghestan Global Study-wide 1134 G=0.6217 A=0.3783
Genome-wide autozygosity in Daghestan Daghestan Sub 628 G=0.646 A=0.354
Genome-wide autozygosity in Daghestan Near_East Sub 144 G=0.583 A=0.417
Genome-wide autozygosity in Daghestan Central Asia Sub 120 G=0.625 A=0.375
Genome-wide autozygosity in Daghestan Europe Sub 108 G=0.639 A=0.361
Genome-wide autozygosity in Daghestan South Asian Sub 98 G=0.51 A=0.49
Genome-wide autozygosity in Daghestan Caucasus Sub 36 G=0.58 A=0.42
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 G=0.644 A=0.356
CNV burdens in cranial meningiomas Global Study-wide 792 G=0.462 A=0.538
CNV burdens in cranial meningiomas CRM Sub 792 G=0.462 A=0.538
A Vietnamese Genetic Variation Database Global Study-wide 614 G=0.441 A=0.559
Northern Sweden ACPOP Study-wide 600 G=0.572 A=0.428
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 G=0.618 A=0.382
SGDP_PRJ Global Study-wide 406 G=0.330 A=0.670
FINRISK Finnish from FINRISK project Study-wide 304 G=0.579 A=0.421
Qatari Global Study-wide 216 G=0.630 A=0.370
Ancient Sardinia genome-wide 1240k capture data generation and analysis Global Study-wide 94 G=0.68 A=0.32
Siberian Global Study-wide 38 G=0.39 A=0.61
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 5 NC_000005.10:g.148826877G>A
GRCh38.p14 chr 5 NC_000005.10:g.148826877G>C
GRCh37.p13 chr 5 NC_000005.9:g.148206440G>A
GRCh37.p13 chr 5 NC_000005.9:g.148206440G>C
ADRB2 RefSeqGene NG_016421.2:g.5285G>A
ADRB2 RefSeqGene NG_016421.2:g.5285G>C
LOC127404222 genomic region NG_106171.1:g.52G>A
LOC127404222 genomic region NG_106171.1:g.52G>C
LOC129994952 genomic region NG_174398.1:g.238G>A
LOC129994952 genomic region NG_174398.1:g.238G>C
Gene: ADRB2, adrenoceptor beta 2 (plus strand)
Molecule type Change Amino acid[Codon] SO Term
ADRB2 transcript NM_000024.6:c.46G>A G [GGA] > R [AGA] Coding Sequence Variant
beta-2 adrenergic receptor NP_000015.2:p.Gly16Arg G (Gly) > R (Arg) Missense Variant
ADRB2 transcript NM_000024.6:c.46G>C G [GGA] > R [CGA] Coding Sequence Variant
beta-2 adrenergic receptor NP_000015.2:p.Gly16Arg G (Gly) > R (Arg) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: G= (allele ID: 32781 )
ClinVar Accession Disease Names Clinical Significance
RCV000019316.12 RECLASSIFIED - ADRB2 POLYMORPHISM Benign
RCV000873016.12 not provided Benign
Allele: A (allele ID: 227753 )
ClinVar Accession Disease Names Clinical Significance
RCV000211334.13 salmeterol response - Efficacy Drug-Response
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement G= A C
GRCh38.p14 chr 5 NC_000005.10:g.148826877= NC_000005.10:g.148826877G>A NC_000005.10:g.148826877G>C
GRCh37.p13 chr 5 NC_000005.9:g.148206440= NC_000005.9:g.148206440G>A NC_000005.9:g.148206440G>C
ADRB2 RefSeqGene NG_016421.2:g.5285= NG_016421.2:g.5285G>A NG_016421.2:g.5285G>C
ADRB2 transcript NM_000024.6:c.46= NM_000024.6:c.46G>A NM_000024.6:c.46G>C
ADRB2 transcript NM_000024.5:c.46A>G NM_000024.5:c.46= NM_000024.5:c.46A>C
LOC127404222 genomic region NG_106171.1:g.52= NG_106171.1:g.52G>A NG_106171.1:g.52G>C
LOC129994952 genomic region NG_174398.1:g.238= NG_174398.1:g.238G>A NG_174398.1:g.238G>C
beta-2 adrenergic receptor NP_000015.2:p.Gly16= NP_000015.2:p.Gly16Arg NP_000015.2:p.Gly16Arg
beta-2 adrenergic receptor NP_000015.1:p.Arg16Gly NP_000015.1:p.Arg16= NP_000015.1:p.Arg16=
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

230 SubSNP, 30 Frequency, 3 ClinVar submissions
No Submitter Submission ID Date (Build)
1 LEE ss1510175 Oct 05, 2000 (86)
2 HGBASE ss2420663 Nov 14, 2000 (89)
3 WIAF-CSNP ss3172964 Aug 15, 2001 (98)
4 LEE ss4404103 May 29, 2002 (106)
5 WI_SSAHASNP ss11700213 Jul 11, 2003 (116)
6 HG_BONN_CNS_SNPS ss12586695 Aug 26, 2003 (117)
7 CGAP-GAI ss16227076 Feb 27, 2004 (120)
8 CSHL-HAPMAP ss17068842 Feb 27, 2004 (120)
9 SSAHASNP ss22345189 Apr 05, 2004 (121)
10 IMCJ-GDT ss22886615 Apr 05, 2004 (121)
11 PERLEGEN ss24195702 Sep 20, 2004 (123)
12 MGC_GENOME_DIFF ss28499024 Sep 24, 2004 (126)
13 MGC_GENOME_DIFF ss28514034 Sep 24, 2004 (126)
14 ABI ss42534864 Mar 10, 2006 (126)
15 PGA-UW-FHCRC ss46533167 Mar 10, 2006 (126)
16 SNP500CANCER ss48292444 Mar 10, 2006 (126)
17 APPLERA_GI ss48427716 Mar 10, 2006 (126)
18 UCSF_HG ss49783229 Mar 10, 2006 (126)
19 RIKENSNPRC ss49847810 Mar 10, 2006 (126)
20 ILLUMINA ss65724637 Oct 16, 2006 (127)
21 ILLUMINA ss66665219 Dec 02, 2006 (127)
22 ILLUMINA ss66882731 Dec 02, 2006 (127)
23 ILLUMINA ss66976220 Dec 02, 2006 (127)
24 PHARMGKB_INVEST ss69364150 May 18, 2007 (127)
25 PHARMGKB_PCE ss69365434 May 18, 2007 (127)
26 PHARMGKB_CREATE ss69366351 May 18, 2007 (127)
27 PHARMGKB_PAAR-SJCRH ss69367534 May 18, 2007 (127)
28 PHARMGKB_PHAT ss69368004 May 18, 2007 (127)
29 PHARMGKB_INVEST ss69368899 May 18, 2007 (127)
30 PHARMGKB_APP ss69369607 May 18, 2007 (127)
31 PHARMGKB_APP ss69369807 May 18, 2007 (127)
32 PHARMGKB_APP ss69370063 May 18, 2007 (127)
33 PHARMGKB_APP ss69370305 May 18, 2007 (127)
34 TAPPERS ss69371809 May 18, 2007 (127)
35 ILLUMINA ss70365493 May 18, 2007 (127)
36 ILLUMINA ss70478442 May 23, 2008 (130)
37 ILLUMINA ss71001749 May 18, 2007 (127)
38 AFFY ss74806164 Aug 16, 2007 (128)
39 ILLUMINA ss75880493 Dec 07, 2007 (129)
40 KRIBB_YJKIM ss83672239 Dec 14, 2007 (130)
41 PHARMGKB_GERA ss84129414 Dec 14, 2007 (130)
42 BCMHGSC_JDW ss93286310 Mar 24, 2008 (129)
43 HUMANGENOME_JCVI ss98775116 Feb 03, 2009 (130)
44 BGI ss104249462 Dec 01, 2009 (131)
45 PHARMGKB_PEAR ss105108110 Feb 03, 2009 (130)
46 PHARMGKB_INVEST ss105110340 Feb 03, 2009 (130)
47 PHARMGKB_INVEST ss105110341 Feb 03, 2009 (130)
48 1000GENOMES ss109502585 Jan 24, 2009 (130)
49 1000GENOMES ss113428990 Jan 25, 2009 (130)
50 ILLUMINA ss121304675 Dec 01, 2009 (131)
51 ENSEMBL ss143519821 Dec 01, 2009 (131)
52 ILLUMINA ss152723827 Dec 01, 2009 (131)
53 GMI ss156154944 Dec 01, 2009 (131)
54 ILLUMINA ss159123185 Dec 01, 2009 (131)
55 SEATTLESEQ ss159710481 Dec 01, 2009 (131)
56 ILLUMINA ss159892647 Dec 01, 2009 (131)
57 COMPLETE_GENOMICS ss162755498 Jul 04, 2010 (132)
58 COMPLETE_GENOMICS ss165962396 Jul 04, 2010 (132)
59 ILLUMINA ss169382035 Jul 04, 2010 (132)
60 ILLUMINA ss170065502 Jul 04, 2010 (132)
61 PHARMGKB_PHAT ss181129035 Jul 04, 2010 (132)
62 BUSHMAN ss201006929 Jul 04, 2010 (132)
63 BCM-HGSC-SUB ss207090862 Jul 04, 2010 (132)
64 1000GENOMES ss222028643 Jul 14, 2010 (132)
65 1000GENOMES ss233192411 Jul 14, 2010 (132)
66 1000GENOMES ss240305953 Jul 15, 2010 (132)
67 ILLUMINA ss244268885 Jul 04, 2010 (132)
68 RSG_JCVI ss262866270 May 09, 2011 (134)
69 OMICIA ss275516154 Nov 30, 2010 (133)
70 OMIM-CURATED-RECORDS ss275517990 Dec 03, 2010 (133)
71 GMI ss278525021 May 04, 2012 (137)
72 GMI ss285280528 Apr 25, 2013 (138)
73 PJP ss293490462 May 09, 2011 (134)
74 NHLBI-ESP ss342193380 May 09, 2011 (134)
75 ILLUMINA ss479264299 May 04, 2012 (137)
76 ILLUMINA ss479267200 May 04, 2012 (137)
77 ILLUMINA ss479636436 Sep 08, 2015 (146)
78 ILLUMINA ss484432818 May 04, 2012 (137)
79 1000GENOMES ss490913369 May 04, 2012 (137)
80 EXOME_CHIP ss491373622 May 04, 2012 (137)
81 CLINSEQ_SNP ss491875586 May 04, 2012 (137)
82 ILLUMINA ss536604145 Sep 08, 2015 (146)
83 TISHKOFF ss558785523 Apr 25, 2013 (138)
84 SSMP ss652689236 Apr 25, 2013 (138)
85 ILLUMINA ss778731096 Sep 08, 2015 (146)
86 ILLUMINA ss780842350 Sep 08, 2015 (146)
87 ILLUMINA ss782662873 Sep 08, 2015 (146)
88 ILLUMINA ss783525720 Sep 08, 2015 (146)
89 ILLUMINA ss783631755 Sep 08, 2015 (146)
90 ILLUMINA ss825335224 Jul 19, 2016 (147)
91 ILLUMINA ss831913401 Sep 08, 2015 (146)
92 ILLUMINA ss832635904 Jul 13, 2019 (153)
93 ILLUMINA ss834190591 Sep 08, 2015 (146)
94 EVA-GONL ss982244496 Aug 21, 2014 (142)
95 JMKIDD_LAB ss1067472509 Aug 21, 2014 (142)
96 JMKIDD_LAB ss1073130452 Aug 21, 2014 (142)
97 1000GENOMES ss1317693445 Aug 21, 2014 (142)
98 HAMMER_LAB ss1397430768 Sep 08, 2015 (146)
99 DDI ss1430535519 Apr 01, 2015 (144)
100 EVA_FINRISK ss1584041837 Apr 01, 2015 (144)
101 EVA_DECODE ss1591776847 Apr 01, 2015 (144)
102 EVA_UK10K_ALSPAC ss1614268113 Apr 01, 2015 (144)
103 EVA_UK10K_TWINSUK ss1657262146 Apr 01, 2015 (144)
104 EVA_EXAC ss1688029151 Apr 01, 2015 (144)
105 EVA_MGP ss1711101805 Apr 01, 2015 (144)
106 EVA_SVP ss1712809104 Apr 01, 2015 (144)
107 ILLUMINA ss1752555223 Sep 08, 2015 (146)
108 ILLUMINA ss1917795747 Feb 12, 2016 (147)
109 WEILL_CORNELL_DGM ss1925498521 Feb 12, 2016 (147)
110 ILLUMINA ss1958832772 Feb 12, 2016 (147)
111 GENOMED ss1970234529 Jul 19, 2016 (147)
112 JJLAB ss2023356559 Sep 14, 2016 (149)
113 USC_VALOUEV ss2151515050 Dec 20, 2016 (150)
114 HUMAN_LONGEVITY ss2279156582 Dec 20, 2016 (150)
115 SYSTEMSBIOZJU ss2626166627 Nov 08, 2017 (151)
116 ILLUMINA ss2634354526 Nov 08, 2017 (151)
117 ILLUMINA ss2634354527 Nov 08, 2017 (151)
118 GRF ss2707084331 Nov 08, 2017 (151)
119 ILLUMINA ss2711051569 Nov 08, 2017 (151)
120 GNOMAD ss2735340113 Nov 08, 2017 (151)
121 GNOMAD ss2747484741 Nov 08, 2017 (151)
122 GNOMAD ss2832147591 Nov 08, 2017 (151)
123 AFFY ss2985339159 Nov 08, 2017 (151)
124 AFFY ss2985970868 Nov 08, 2017 (151)
125 SWEGEN ss2997982675 Nov 08, 2017 (151)
126 ILLUMINA ss3022540966 Nov 08, 2017 (151)
127 EVA_SAMSUNG_MC ss3023061570 Nov 08, 2017 (151)
128 BIOINF_KMB_FNS_UNIBA ss3025460092 Nov 08, 2017 (151)
129 CSHL ss3346678470 Nov 08, 2017 (151)
130 ILLUMINA ss3629367632 Oct 12, 2018 (152)
131 ILLUMINA ss3629367633 Oct 12, 2018 (152)
132 ILLUMINA ss3632277640 Oct 12, 2018 (152)
133 ILLUMINA ss3633393764 Oct 12, 2018 (152)
134 ILLUMINA ss3634115127 Oct 12, 2018 (152)
135 ILLUMINA ss3635027929 Oct 12, 2018 (152)
136 ILLUMINA ss3635027930 Oct 12, 2018 (152)
137 ILLUMINA ss3635796774 Oct 12, 2018 (152)
138 ILLUMINA ss3636741120 Oct 12, 2018 (152)
139 ILLUMINA ss3637549430 Oct 12, 2018 (152)
140 ILLUMINA ss3638587578 Oct 12, 2018 (152)
141 ILLUMINA ss3639296034 Oct 12, 2018 (152)
142 ILLUMINA ss3639672341 Oct 12, 2018 (152)
143 ILLUMINA ss3640735223 Oct 12, 2018 (152)
144 ILLUMINA ss3640735224 Oct 12, 2018 (152)
145 ILLUMINA ss3643531063 Oct 12, 2018 (152)
146 ILLUMINA ss3644891852 Oct 12, 2018 (152)
147 OMUKHERJEE_ADBS ss3646326216 Oct 12, 2018 (152)
148 URBANLAB ss3648194722 Oct 12, 2018 (152)
149 ILLUMINA ss3653043945 Oct 12, 2018 (152)
150 ILLUMINA ss3654111345 Oct 12, 2018 (152)
151 EGCUT_WGS ss3665902714 Jul 13, 2019 (153)
152 PATHPUNJABI ss3685990252 Jul 13, 2019 (153)
153 EVA_DECODE ss3715930580 Jul 13, 2019 (153)
154 ILLUMINA ss3726280661 Jul 13, 2019 (153)
155 ACPOP ss3732916313 Jul 13, 2019 (153)
156 ILLUMINA ss3744541929 Jul 13, 2019 (153)
157 ILLUMINA ss3745328103 Jul 13, 2019 (153)
158 ILLUMINA ss3745328104 Jul 13, 2019 (153)
159 EVA ss3764207361 Jul 13, 2019 (153)
160 PAGE_CC ss3771239015 Jul 13, 2019 (153)
161 ILLUMINA ss3772822058 Jul 13, 2019 (153)
162 KHV_HUMAN_GENOMES ss3807376593 Jul 13, 2019 (153)
163 EVA ss3824127581 Apr 26, 2020 (154)
164 EVA ss3825522821 Apr 26, 2020 (154)
165 EVA ss3825538913 Apr 26, 2020 (154)
166 EVA ss3825682927 Apr 26, 2020 (154)
167 EVA ss3829561448 Apr 26, 2020 (154)
168 EVA ss3838254709 Apr 26, 2020 (154)
169 EVA ss3843697752 Apr 26, 2020 (154)
170 HGDP ss3847810705 Apr 26, 2020 (154)
171 SGDP_PRJ ss3863219823 Apr 26, 2020 (154)
172 KRGDB ss3909894975 Apr 26, 2020 (154)
173 KOGIC ss3957872244 Apr 26, 2020 (154)
174 FSA-LAB ss3984319573 Apr 26, 2021 (155)
175 FSA-LAB ss3984319574 Apr 26, 2021 (155)
176 EVA ss3984448336 Apr 26, 2021 (155)
177 EVA ss3984556071 Apr 26, 2021 (155)
178 EVA ss3985177323 Apr 26, 2021 (155)
179 EVA ss3986032110 Apr 26, 2021 (155)
180 EVA ss3986324011 Apr 26, 2021 (155)
181 EVA ss4017237517 Apr 26, 2021 (155)
182 TOPMED ss4682905237 Apr 26, 2021 (155)
183 TOMMO_GENOMICS ss6058741026 Oct 30, 2024 (157)
184 EVA ss6233055081 Oct 30, 2024 (157)
185 EVA ss6296898065 Oct 30, 2024 (157)
186 EVA ss6321919903 Oct 30, 2024 (157)
187 EVA ss6322253485 Oct 30, 2024 (157)
188 EVA ss6324851735 Oct 30, 2024 (157)
189 EVA ss6330893507 Oct 30, 2024 (157)
190 YEGNASUBRAMANIAN_LAB ss6339103298 Oct 30, 2024 (157)
191 EVA ss6349646238 Oct 30, 2024 (157)
192 EVA ss6350033584 Oct 30, 2024 (157)
193 KOGIC ss6368561732 Oct 30, 2024 (157)
194 EVA ss6404337756 Oct 30, 2024 (157)
195 EVA ss6404572586 Oct 30, 2024 (157)
196 GNOMAD ss6425672178 Oct 30, 2024 (157)
197 GNOMAD ss6696588940 Oct 30, 2024 (157)
198 TOMMO_GENOMICS ss8174683000 Oct 30, 2024 (157)
199 EVA ss8237017010 Oct 30, 2024 (157)
200 EVA ss8237187693 Oct 30, 2024 (157)
201 EVA ss8237644488 Oct 30, 2024 (157)
202 1000G_HIGH_COVERAGE ss8266260622 Oct 30, 2024 (157)
203 TRAN_CS_UWATERLOO ss8314414098 Oct 30, 2024 (157)
204 EVA ss8315094239 Oct 30, 2024 (157)
205 EVA ss8361730390 Oct 30, 2024 (157)
206 HUGCELL_USP ss8464182326 Oct 30, 2024 (157)
207 1000G_HIGH_COVERAGE ss8551124911 Oct 30, 2024 (157)
208 EVA ss8623933648 Oct 30, 2024 (157)
209 EVA ss8624151363 Oct 30, 2024 (157)
210 SANFORD_IMAGENETICS ss8624604684 Oct 30, 2024 (157)
211 SANFORD_IMAGENETICS ss8639116923 Oct 30, 2024 (157)
212 TOMMO_GENOMICS ss8711918947 Oct 30, 2024 (157)
213 EVA ss8799402156 Oct 30, 2024 (157)
214 EVA ss8799665360 Oct 30, 2024 (157)
215 EVA ss8800124845 Oct 30, 2024 (157)
216 YY_MCH ss8806865896 Oct 30, 2024 (157)
217 EVA ss8835802314 Oct 30, 2024 (157)
218 EVA ss8847276597 Oct 30, 2024 (157)
219 EVA ss8848069000 Oct 30, 2024 (157)
220 EVA ss8848637779 Oct 30, 2024 (157)
221 EVA ss8855064162 Oct 30, 2024 (157)
222 EVA ss8896806214 Oct 30, 2024 (157)
223 EVA ss8936528408 Oct 30, 2024 (157)
224 EVA ss8967595842 Oct 30, 2024 (157)
225 EVA ss8979758246 Oct 30, 2024 (157)
226 EVA ss8980322575 Oct 30, 2024 (157)
227 EVA ss8981943613 Oct 30, 2024 (157)
228 EVA ss8981943614 Oct 30, 2024 (157)
229 EVA ss8982029380 Oct 30, 2024 (157)
230 EVA ss8982507999 Oct 30, 2024 (157)
231 1000Genomes NC_000005.9 - 148206440 Oct 12, 2018 (152)
232 1000Genomes_30X NC_000005.10 - 148826877 Oct 30, 2024 (157)
233 The Avon Longitudinal Study of Parents and Children NC_000005.9 - 148206440 Oct 12, 2018 (152)
234 Genome-wide autozygosity in Daghestan NC_000005.8 - 148186633 Apr 26, 2020 (154)
235 Genetic variation in the Estonian population NC_000005.9 - 148206440 Oct 12, 2018 (152)
236 ExAC NC_000005.9 - 148206440 Oct 12, 2018 (152)
237 FINRISK NC_000005.9 - 148206440 Apr 26, 2020 (154)
238 gnomAD v4 - Exomes NC_000005.10 - 148826877 Oct 30, 2024 (157)
239 gnomAD v4 - Genomes NC_000005.10 - 148826877 Oct 30, 2024 (157)
240 Genome of the Netherlands Release 5 NC_000005.9 - 148206440 Apr 26, 2020 (154)
241 HGDP-CEPH-db Supplement 1 NC_000005.8 - 148186633 Apr 26, 2020 (154)
242 HapMap NC_000005.10 - 148826877 Apr 26, 2020 (154)
243 KOREAN population from KRGDB NC_000005.9 - 148206440 Apr 26, 2020 (154)
244 Korean Genome Project NC_000005.10 - 148826877 Apr 26, 2020 (154)
245 Korean Genome Project 4K NC_000005.10 - 148826877 Oct 30, 2024 (157)
246 Medical Genome Project healthy controls from Spanish population NC_000005.9 - 148206440 Apr 26, 2020 (154)
247 Northern Sweden NC_000005.9 - 148206440 Jul 13, 2019 (153)
248 The PAGE Study NC_000005.10 - 148826877 Jul 13, 2019 (153)
249 Ancient Sardinia genome-wide 1240k capture data generation and analysis NC_000005.9 - 148206440 Apr 26, 2021 (155)
250 CNV burdens in cranial meningiomas NC_000005.9 - 148206440 Apr 26, 2021 (155)
251 MxGDAR/Encodat-PGx NC_000005.9 - 148206440 Apr 26, 2021 (155)
252 PharmGKB Aggregated NC_000005.10 - 148826877 Apr 26, 2020 (154)
253 Qatari NC_000005.9 - 148206440 Apr 26, 2020 (154)
254 SGDP_PRJ NC_000005.9 - 148206440 Apr 26, 2020 (154)
255 Siberian NC_000005.9 - 148206440 Apr 26, 2020 (154)
256 38KJPN NC_000005.10 - 148826877 Oct 30, 2024 (157)
257 TopMed NC_000005.10 - 148826877 Apr 26, 2021 (155)
258 UK 10K study - Twins NC_000005.9 - 148206440 Oct 12, 2018 (152)
259 A Vietnamese Genetic Variation Database NC_000005.9 - 148206440 Jul 13, 2019 (153)
260 ALFA NC_000005.10 - 148826877 Oct 30, 2024 (157)
261 ClinVar RCV000019316.12 Oct 30, 2024 (157)
262 ClinVar RCV000211334.13 Oct 30, 2024 (157)
263 ClinVar RCV000873016.12 Oct 30, 2024 (157)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs3182174 Jul 03, 2002 (106)
rs3729940 Oct 08, 2002 (108)
rs17287432 Mar 10, 2006 (126)
rs17334179 Mar 10, 2006 (126)
rs17334242 Mar 10, 2006 (126)
rs17721693 Oct 08, 2004 (123)
rs17839749 Oct 08, 2004 (123)
rs17846639 Mar 10, 2006 (126)
rs17859732 Mar 10, 2006 (126)
rs52812686 Sep 21, 2007 (128)
rs56964295 May 23, 2008 (130)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
405581, 488597, ss93286310, ss109502585, ss113428990, ss162755498, ss165962396, ss201006929, ss207090862, ss278525021, ss285280528, ss293490462, ss479264299, ss491875586, ss825335224, ss1397430768, ss1591776847, ss1712809104, ss3639296034, ss3639672341, ss3643531063, ss3847810705 NC_000005.8:148186632:G:A NC_000005.10:148826876:G:A (self)
29388919, 16351762, 11640962, 8038234, 38298, 7260316, 17072369, 217565, 6201178, 403250, 105443, 1337, 7540451, 15236803, 4031404, 16351762, 3624066, ss222028643, ss233192411, ss240305953, ss342193380, ss479267200, ss479636436, ss484432818, ss490913369, ss491373622, ss536604145, ss558785523, ss652689236, ss778731096, ss780842350, ss782662873, ss783525720, ss783631755, ss831913401, ss832635904, ss834190591, ss982244496, ss1067472509, ss1073130452, ss1317693445, ss1430535519, ss1584041837, ss1614268113, ss1657262146, ss1688029151, ss1711101805, ss1752555223, ss1917795747, ss1925498521, ss1958832772, ss1970234529, ss2023356559, ss2151515050, ss2626166627, ss2634354526, ss2634354527, ss2707084331, ss2711051569, ss2735340113, ss2747484741, ss2832147591, ss2985339159, ss2985970868, ss2997982675, ss3022540966, ss3023061570, ss3346678470, ss3629367632, ss3629367633, ss3632277640, ss3633393764, ss3634115127, ss3635027929, ss3635027930, ss3635796774, ss3636741120, ss3637549430, ss3638587578, ss3640735223, ss3640735224, ss3644891852, ss3646326216, ss3653043945, ss3654111345, ss3665902714, ss3732916313, ss3744541929, ss3745328103, ss3745328104, ss3764207361, ss3772822058, ss3824127581, ss3825522821, ss3825538913, ss3825682927, ss3829561448, ss3838254709, ss3863219823, ss3909894975, ss3984319573, ss3984319574, ss3984448336, ss3984556071, ss3985177323, ss3986032110, ss3986324011, ss4017237517, ss6233055081, ss6296898065, ss6322253485, ss6324851735, ss6330893507, ss6339103298, ss6349646238, ss6350033584, ss6404572586, ss8174683000, ss8315094239, ss8361730390, ss8623933648, ss8624151363, ss8624604684, ss8639116923, ss8799402156, ss8799665360, ss8800124845, ss8835802314, ss8847276597, ss8848069000, ss8848637779, ss8936528408, ss8967595842, ss8979758246, ss8980322575, ss8981943613, ss8981943614, ss8982507999 NC_000005.9:148206439:G:A NC_000005.10:148826876:G:A (self)
RCV000211334.13, 38650846, 20982448, 223331782, 2992217, 14250245, 18413630, 460484, 10503, 76116846, 520282794, 3116550438, ss275516154, ss275517990, ss2279156582, ss3025460092, ss3648194722, ss3685990252, ss3715930580, ss3726280661, ss3771239015, ss3807376593, ss3843697752, ss3957872244, ss4682905237, ss6058741026, ss6321919903, ss6368561732, ss6404337756, ss6425672178, ss6696588940, ss8237017010, ss8237187693, ss8237644488, ss8266260622, ss8314414098, ss8464182326, ss8551124911, ss8711918947, ss8806865896, ss8855064162, ss8896806214, ss8982029380 NC_000005.10:148826876:G:A NC_000005.10:148826876:G:A (self)
ss11700213 NT_029289.9:9369376:G:A NC_000005.10:148826876:G:A (self)
ss17068842, ss22345189 NT_029289.10:9369375:G:A NC_000005.10:148826876:G:A (self)
ss1510175, ss2420663, ss3172964, ss4404103, ss12586695, ss16227076, ss22886615, ss24195702, ss28499024, ss28514034, ss42534864, ss46533167, ss48292444, ss48427716, ss49783229, ss49847810, ss65724637, ss66665219, ss66882731, ss66976220, ss69364150, ss69365434, ss69366351, ss69367534, ss69368004, ss69368899, ss69369607, ss69369807, ss69370063, ss69370305, ss69371809, ss70365493, ss70478442, ss71001749, ss74806164, ss75880493, ss83672239, ss84129414, ss98775116, ss104249462, ss105108110, ss105110340, ss105110341, ss121304675, ss143519821, ss152723827, ss156154944, ss159123185, ss159710481, ss159892647, ss169382035, ss170065502, ss181129035, ss244268885, ss262866270 NT_029289.11:9369366:G:A NC_000005.10:148826876:G:A (self)
17072369, ss3909894975 NC_000005.9:148206439:G:C NC_000005.10:148826876:G:C (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

221 citations for rs1042713
PMID Title Author Year Journal
7706471 Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. Turki J et al. 1995 The Journal of clinical investigation
9399946 Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. Large V et al. 1997 The Journal of clinical investigation
9399966 Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. Martinez FD et al. 1997 The Journal of clinical investigation
9522789 Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based study. Hopes E et al. 1998 BMJ (Clinical research ed.)
11739457 The effect of the Gly16Arg polymorphism of the beta(2)-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity. Meirhaeghe A et al. 2001 The Journal of clinical endocrinology and metabolism
14557466 The Gly16-->Arg16 and Gln27-->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. Dallongeville J et al. 2003 The Journal of clinical endocrinology and metabolism
15500681 Detecting imbalanced expression of SNP alleles by minisequencing on microarrays. Liljedahl U et al. 2004 BMC biotechnology
15500895 Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Israel E et al. 2004 Lancet (London, England)
15726497 Gene-environment interaction effects on the development of immune responses in the 1st year of life. Hoffjan S et al. 2005 American journal of human genetics
15867853 Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. Contopoulos-Ioannidis DG et al. 2005 The Journal of allergy and clinical immunology
16322642 beta-Adrenergic receptor polymorphisms and response to salmeterol. Wechsler ME et al. 2006 American journal of respiratory and critical care medicine
16385446 A testing framework for identifying susceptibility genes in the presence of epistasis. Millstein J et al. 2006 American journal of human genetics
16595073 Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations. Savas S et al. 2006 Human genomics
16596417 Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics. Tsai HJ et al. 2006 Human genetics
16741943 Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Diatchenko L et al. 2006 American journal of medical genetics. Part B, Neuropsychiatric genetics
16772309 Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Palmer CN et al. 2006 Thorax
16935688 Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study. Hall IP et al. 2006 Lancet (London, England)
17143563 beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease. Jazdzewski K et al. 2007 International journal of molecular medicine
17150099 Beta2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus. Pinelli M et al. 2006 BMC medical genetics
17199132 beta2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort. Cheslack-Postava K et al. 2007 Molecular psychiatry
17512307 Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Lima JJ et al. 2007 Metabolism
18156033 Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Bleecker ER et al. 2007 Lancet (London, England)
18191955 Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Zhu Y et al. 2008 Mutation research
18304332 No evidence for association between BMI and 10 candidate genes at ages 4, 7 and 10 in a large UK sample of twins. Haworth CM et al. 2008 BMC medical genetics
18482449 Investigating the complex genetic architecture of ankle-brachial index, a measure of peripheral arterial disease, in non-Hispanic whites. Kardia SL et al. 2008 BMC medical genomics
18513389 New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. Penco S et al. 2008 BMC bioinformatics
18534365 Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease. Tseng ZH et al. 2008 Heart rhythm
18599530 Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients. Feng Y et al. 2008 Diabetes care
18603647 Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Simoni M et al. 2008 Human reproduction update
18615004 beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension. Pacanowski MA et al. 2008 Clinical pharmacology and therapeutics
18640383 Genotypes and haplotypes of beta2-adrenergic receptor and parameters of the metabolic syndrome in Korean adolescents. Park HS et al. 2008 Metabolism
18647184 Association between polymorphisms in the beta2-adrenoceptor gene and migraine in women. Schürks M et al. 2009 Headache
18709160 Interactions between glutathione S-transferase P1, tumor necrosis factor, and traffic-related air pollution for development of childhood allergic disease. Melén E et al. 2008 Environmental health perspectives
18719656
18936436 Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Chang MH et al. 2009 American journal of epidemiology
19111454 Genetic association analysis of COPD candidate genes with bronchodilator responsiveness. Kim WJ et al. 2009 Respiratory medicine
19131662 A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Wang X et al. 2009 Stroke
19186333 Association of codon 16 and codon 27 beta 2-adrenergic receptor gene polymorphisms with obesity: a meta-analysis. Jalba MS et al. 2008 Obesity (Silver Spring, Md.)
19190821 Association between polymorphisms in the beta2-adrenergic receptor gene with myocardial infarction and ischaemic stroke in women. Schürks M et al. 2009 Thrombosis and haemostasis
19263529 Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach. Zee RY et al. 2009 Clinica chimica acta; international journal of clinical chemistry
19284637 Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence. Chu X et al. 2009 BMC medical genetics
19330901 Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study. Conen D et al. 2009 Journal of hypertension
19553224 Trp64Arg polymorphism in ADRB3 gene is associated with elite endurance performance. Santiago C et al. 2011 British journal of sports medicine
19559392 A candidate gene association study of 77 polymorphisms in migraine. Schürks M et al. 2009 The journal of pain
19565482 Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains. Vargas-Alarcón G et al. 2009 Arthritis and rheumatism
19576569 Diverse evolutionary histories for beta-adrenoreceptor genes in humans. Cagliani R et al. 2009 American journal of human genetics
19619703 Association of genetic variants with the metabolic syndrome in 20,806 white women: The Women's Health Genome Study. Goulart AC et al. 2009 American heart journal
19717003 Pediatric obesity: etiology and treatment. Crocker MK et al. 2009 Endocrinology and metabolism clinics of North America
19736300 Genetic basis of inter-individual variability in the effects of exercise on the alleviation of lifestyle-related diseases. Mori M et al. 2009 The Journal of physiology
19745160 Trend tests for genetic association using population-based cross-sectional complex survey data. She D et al. 2010 Biostatistics (Oxford, England)
19779622 No consistent effect of ADRB2 haplotypes on obesity, hypertension and quantitative traits of body fatness and blood pressure among 6,514 adult Danes. Gjesing AP et al. 2009 PloS one
19800676 Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol. Basu K et al. 2009 The Journal of allergy and clinical immunology
19932356 Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Wechsler ME et al. 2009 Lancet (London, England)
19933216 The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Castaldi PJ et al. 2010 Human molecular genetics
20044476 Associations of polymorphisms of eight muscle- or metabolism-related genes with performance in Mount Olympus marathon runners. Tsianos GI et al. 2010 Journal of applied physiology (Bethesda, Md.
20049212 Traffic-related air pollution, oxidative stress genes, and asthma (ECHRS). Castro-Giner F et al. 2009 Environmental health perspectives
20078877 Gene polymorphisms in association with emerging cardiovascular risk markers in adult women. Fan AZ et al. 2010 BMC medical genetics
20167428 Genetic variation in the beta2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: results from the 1958 British Birth Cohort Study. Hocking LJ et al. 2010 Pain
20230274 Polymorphisms in the ACE and ADRB2 genes and risks of aging-associated phenotypes: the case of myocardial infarction. Kulminski AM et al. 2010 Rejuvenation research
20401335 Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype. Driss A et al. 2009 Genomics insights
20417488 Association of fetal inflammation and coagulation pathway gene polymorphisms with neurodevelopmental delay at age 2 years. Clark EA et al. 2010 American journal of obstetrics and gynecology
20435227 Clinical assessment incorporating a personal genome. Ashley EA et al. 2010 Lancet (London, England)
20521218 Progress toward genetic tailoring of heart failure therapy. Lillvis JH et al. 2010 Current opinion in molecular therapeutics
20523301 Role of β₂-adrenergic receptor polymorphisms on body weight and body composition response to energy restriction in obese women: preliminary results. Ruiz JR et al. 2011 Obesity (Silver Spring, Md.)
20525719 Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD. Kim WJ et al. 2011 The European respiratory journal
20537997 Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins. Loomba R et al. 2010 Gastroenterology
20592916 Pharmacogenomic approaches to asthma treatment. Cho SH et al. 2010 Allergy, asthma & immunology research
20810793 Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant. Bambha K et al. 2010 Mayo Clinic proceedings
20816195 Analyses of shared genetic factors between asthma and obesity in children. Melén E et al. 2010 The Journal of allergy and clinical immunology
20869266 Single-nucleotide polymorphisms in the β-adrenergic receptor genes are associated with lung allograft utilization. Sapru A et al. 2011 The Journal of heart and lung transplantation
20941391 Genetic variants and their interactions in the prediction of increased pre-clinical carotid atherosclerosis: the cardiovascular risk in young Finns study. Okser S et al. 2010 PLoS genetics
20981351 Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study. Sugimoto K et al. 2010 International journal of hypertension
21054877 Inflammation gene variants and susceptibility to albuminuria in the U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-1994. Ned RM et al. 2010 BMC medical genetics
21233812 ADRB2 and LEPR gene polymorphisms: synergistic effects on the risk of obesity in Japanese. Pereira TV et al. 2011 Obesity (Silver Spring, Md.)
21414566 β2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study. Vardeny O et al. 2011 Journal of the American Society of Hypertension
21437030 Genetics and cardiovascular system: influence of human genetic variants on vascular function. Dias RG et al. 2011 Genes & nutrition
21515823 Genetic predictors for stroke in children with sickle cell anemia. Flanagan JM et al. 2011 Blood
21573014 Genes involved in vasoconstriction and vasodilation system affect salt-sensitive hypertension. Citterio L et al. 2011 PloS one
21573230 Clustering heart rate dynamics is associated with β-adrenergic receptor polymorphisms: analysis by information-based similarity index. Yang AC et al. 2011 PloS one
21613201 The effect of maternal and fetal β2-adrenoceptor and nitric oxide synthase genotype on vasopressor requirement and fetal acid-base status during spinal anesthesia for cesarean delivery. Landau R et al. 2011 Anesthesia and analgesia
21807569 β-1 and β-2 adrenergic receptor polymorphism and association with cardiovascular response to orthostatic screening. Wittwer ED et al. 2011 Autonomic neuroscience
21883537 β2 -adrenergic receptor Thr164IIe polymorphism, blood pressure and ischaemic heart disease in 66 750 individuals. Thomsen M et al. 2012 Journal of internal medicine
21894447 Are centenarians genetically predisposed to lower disease risk? Ruiz JR et al. 2012 Age (Dordrecht, Netherlands)
21981957 Pediatric obesity: etiology and treatment. Crocker MK et al. 2011 Pediatric clinics of North America
22058430 Genetic basis of pain variability: recent advances. Young EE et al. 2012 Journal of medical genetics
22355322 Gene-gene and gene-environmental interactions of childhood asthma: a multifactor dimension reduction approach. Su MW et al. 2012 PloS one
22383665 ADRB2 polymorphisms and budesonide/formoterol responses in COPD. Bleecker ER et al. 2012 Chest
22552919 Bioinformatics and variability in drug response: a protein structural perspective. Lahti JL et al. 2012 Journal of the Royal Society, Interface
22624056 Genetic variation in the β2-adrenocepter gene is associated with susceptibility to bacterial meningitis in adults. Adriani KS et al. 2012 PloS one
22769019 Association of inflammatory gene polymorphisms with ischemic stroke in a Chinese Han population. Zhao N et al. 2012 Journal of neuroinflammation
22864926 ADRB2 G-G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity. Connor A et al. 2012 Cancer causes & control
22879966 Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER Study. Verschuren JJ et al. 2012 PloS one
22900502 Association between β2-adrenoceptor (ADRB2) haplotypes and insulin resistance in PCOS. Tellechea ML et al. 2013 Clinical endocrinology
22985077 Associations between genetic polymorphisms of beta-2 adrenergic receptor and preterm delivery in Korean women. Suh YJ et al. 2013 American journal of reproductive immunology (New York, N.Y.
22992668 Pharmacogenomics knowledge for personalized medicine. Whirl-Carrillo M et al. 2012 Clinical pharmacology and therapeutics
23126384 Tailored second-line therapy in asthmatic children with the Arg(16) genotype. Lipworth BJ et al. 2013 Clinical science (London, England
23229623 ADRB2, brain white matter integrity and cognitive ageing in the Lothian Birth Cohort 1936. Lyall DM et al. 2013 Behavior genetics
23229733 A functional SNP upstream of the beta-2 adrenergic receptor gene (ADRB2) is associated with obesity in Oceanic populations. Naka I et al. 2013 International journal of obesity (2005)
23267696 Association of genetic polymorphisms with chronic obstructive pulmonary disease in the Chinese Han population: a case-control study. Guo Y et al. 2012 BMC medical genomics
23300409 Chapter 7: Pharmacogenomics. Karczewski KJ et al. 2012 PLoS computational biology
23463918 Childhood lung function and the association with β2-adrenergic receptor haplotypes. Torjussen TM et al. 2013 Acta paediatrica (Oslo, Norway
23766564 Pharmacogenetics of chronic pain and its treatment. Světlík S et al. 2013 Mediators of inflammation
23786226 Genetic variation in the beta-2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health-related quality of life. Kushnir VM et al. 2013 Alimentary pharmacology & therapeutics
23820649 Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Cooper DN et al. 2013 Human genetics
23912588 Pharmacogenetics and the development of personalized approaches for combination therapy in asthma. Miller SM et al. 2013 Current allergy and asthma reports
24012958 Single nucleotide polymorphisms of ADRB2 gene and their association with susceptibility for Plasmodium falciparum malaria and asthma in an Indian population. Saadi AV et al. 2013 Infection, genetics and evolution
24201779 Genetic variability in energy balance and pancreatic cancer risk in a population-based case-control study in Minnesota. Zhang J et al. 2014 Pancreas
24279851 Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the PACMAN cohort. Zuurhout MJ et al. 2013 Pharmacogenomics
24392269 Gene-Lifestyle Interactions in Obesity. van Vliet-Ostaptchouk JV et al. 2012 Current nutrition reports
24838642 Single nucleotide polymorphisms predisposing to asthma in children of Mauritian Indian and Chinese Han ethnicity. Ramphul K et al. 2014 Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
24879436 Replication of 6 obesity genes in a meta-analysis of genome-wide association studies from diverse ancestries. Tan LJ et al. 2014 PloS one
24944790 Screening for 392 polymorphisms in 141 pharmacogenes. Kim JY et al. 2014 Biomedical reports
24960039 Association of Gln27Glu and Arg16Gly polymorphisms in Beta2-adrenergic receptor gene with obesity susceptibility: a meta-analysis. Zhang H et al. 2014 PloS one
25050782 Effects of β2-adrenergic receptor gene polymorphisms on ritodrine therapy in pregnant women with preterm labor: prospective follow-up study. Park JY et al. 2014 International journal of molecular sciences
25111792 Beta-2 adrenergic receptor (ADRB2) gene polymorphisms and the risk of asthma: a meta-analysis of case-control studies. Liang SQ et al. 2014 PloS one
25266489 Genetic polymorphisms of VIP variants in the Tajik ethnic group of northwest China. Zhang J et al. 2014 BMC genetics
25682119 Genetic factors associated with exercise performance in atmospheric hypoxia. Hennis PJ et al. 2015 Sports medicine (Auckland, N.Z.)
25761120 A genetic predisposition score associates with reduced aerobic capacity in response to acute normobaric hypoxia in lowlanders. Masschelein E et al. 2015 High altitude medicine & biology
25876437 Multifactor-dimensionality reduction reveals interaction of important gene variants involved in allergy. de Guia RM et al. 2015 International journal of immunogenetics
25894531 Pharmacogenetic Effects of Inhaled Salbutamol on 10-km Time Trial Performance in Competitive Male and Female Cyclists. Koch S et al. 2016 Clinical journal of sport medicine
25910744 Association of polymorphisms in the beta-2 adrenergic receptor gene with fracture risk and bone mineral density. Veldhuis-Vlug AG et al. 2015 Osteoporosis international
26091847 Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China. Wang L et al. 2015 BMC genetics
26111150 Association of the ADRB2 (rs2053044) polymorphism and angiotensin-converting enzyme-inhibitor blood pressure response in the African American Study of Kidney Disease and Hypertension. Anthony EG et al. 2015 Pharmacogenetics and genomics
26260058 Two novel genetic variants in the mineralocorticoid receptor gene associated with spontaneous preterm birth. Christiaens I et al. 2015 BMC medical genetics
26369942 β2-Adrenergic receptor promoter haplotype influences the severity of acute viral respiratory tract infection during infancy: a prospective cohort study. Wu P et al. 2015 BMC medical genetics
26373931 Polymorphism profiling of nine high altitude relevant candidate gene loci in acclimatized sojourners and adapted natives. Tomar A et al. 2015 BMC genetics
26503814 A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease. Hardin M et al. 2016 The pharmacogenomics journal
26602751 Association of β-Adrenergic Receptor Gene Polymorphisms With Acute Coronary Syndrome and Cardiovascular Risk Factors in an Arab Population. El-Menyar A et al. 2016 Angiology
26613553 Four-locus gene interaction between IL13, IL4, FCER1B, and ADRB2 for asthma in Chinese Han children. Hua L et al. 2016 Pediatric pulmonology
26774659 Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment. Turner S et al. 2016 The Journal of allergy and clinical immunology
26819062 Characterizing redescriptions using persistent homology to isolate genetic pathways contributing to pathogenesis. Platt DE et al. 2016 BMC systems biology
26879662 Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study. Lee HY et al. 2016 The Korean journal of internal medicine
26982741 Single Nucleotide Variant rs2232710 in the Protein Z-Dependent Protease Inhibitor (ZPI, SERPINA10) Gene Is Not Associated with Deep Vein Thrombosis. Gorski MM et al. 2016 PloS one
27103841 Personalized medicine and treatment approaches in hypertension: current perspectives. Byrd JB et al. 2016 Integrated blood pressure control
27233804 Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China. Jin T et al. 2016 BMC genetics
27247849 Genetic variation and cognitive dysfunction in opioid-treated patients with cancer. Kurita GP et al. 2016 Brain and behavior
27274104 A genetic-based algorithm for personalized resistance training. Jones N et al. 2016 Biology of sport
27277665 Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population. Zholdybayeva EV et al. 2016 Human genomics
27411394 Shared genetic variants between serum levels of high-density lipoprotein cholesterol and wheezing in a cohort of children from Cyprus. Yiallouros PK et al. 2016 Italian journal of pediatrics
27601774 Genetic variants influencing effectiveness of exercise training programmes in obesity - an overview of human studies. Leońska-Duniec A et al. 2016 Biology of sport
27616475 Gene variants as risk factors for gastroschisis. Padula AM et al. 2016 American journal of medical genetics. Part A
27624002 Allergy-specific Phenome-Wide Association Study for Immunogenes in Turkish Children. Karaca S et al. 2016 Scientific reports
27669015 Adrenergic Receptor Polymorphism and Maximal Exercise Capacity after Orthotopic Heart Transplantation. Métrich M et al. 2016 PloS one
27798356 Lack of replication of associations between multiple genetic polymorphisms and endurance athlete status in Japanese population. Yvert T et al. 2016 Physiological reports
27923785 Genetic determination of the vascular reactions in humans in response to the diving reflex. Baranova TI et al. 2017 American journal of physiology. Heart and circulatory physiology
28198454 Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder. Zhang X et al. 2017 Scientific reports
28293925 Genetic Signatures of Asthma Exacerbation. Park HW et al. 2017 Allergy, asthma & immunology research
28294290 Genetic Obesity Risk and Attenuation Effect of Physical Fitness in Mexican-Mestizo Population: a Case-Control Study. Costa-Urrutia P et al. 2017 Annals of human genetics
28327457 Beta(2)-adrenergic receptor gene haplotypes and bronchodilator response in Egyptian patients with chronic obstructive pulmonary disease. Hussein MH et al. 2017 Advances in medical sciences
28350619 Genetic determinants of essential hypertension in the population of Tatars from Russia. Timasheva Y et al. 2017 Journal of hypertension
28487959 Identification of six polymorphisms as novel susceptibility loci for ischemic or hemorrhagic stroke by exome-wide association studies. Yamada Y et al. 2017 International journal of molecular medicine
29132297 Association between ß2-adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: a prospective observational study. Chung JE et al. 2017 BMC genetics
29197114 The correlation between SNPs within the gene of adrenergic receptor and neuropeptide Y and risk of cervical vertigo. Han J et al. 2018 Journal of clinical laboratory analysis
29205277 Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon. Wonkam A et al. 2018 British journal of haematology
29331538 Differential lipid metabolism outcomes associated with ADRB2 gene polymorphisms in response to two dietary interventions in overweight/obese subjects. Ramos-Lopez O et al. 2018 Nutrition, metabolism, and cardiovascular diseases
29550988 Genetic variants conferring susceptibility to gastroschisis: a phenomenon restricted to the interaction with the environment? Salinas-Torres VM et al. 2018 Pediatric surgery international
29620176 β2‑adrenergic receptor functionality and genotype in two different models of chronic inflammatory disease: Liver cirrhosis and osteoarthritis. Roca R et al. 2018 Molecular medicine reports
29703608 Influence of SNPs in Genes that Modulate Lung Disease Severity in a Group of Mexican Patients with Cystic Fibrosis. Yokoyama E et al. 2018 Archives of medical research
29761786 Association of a 4-Locus Gene Model Including IL13, IL4, FCER1B, and ADRB2 With the Asthma Predictive Index and Atopy in Chinese Han Children. Bai S et al. 2018 Journal of investigational allergology & clinical immunology
29876231 Polymorphism of the ADRB2 Rs1042713 Gene is not Associated with Spontaneous Preterm Birth: Analyses in a Slovenian Sample and Meta Analysis. A P et al. 2017 Balkan journal of medical genetics
29992699 Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review. Slob EMA et al. 2018 Pediatric allergy and immunology
30142673 Metabolic Determinants of Impaired Pulmonary Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Röhling M et al. 2018 Experimental and clinical endocrinology & diabetes
30334910 Leveraging electronic health records to assess the role of ADRB2 single nucleotide polymorphisms in predicting exacerbation frequency in asthma patients. Sood N et al. 2018 Pharmacogenetics and genomics
30387422 [Genetic Polymorphisms Associated with the Onset of Arterial Hypertension in a Portuguese Population]. Sousa AC et al. 2018 Acta medica portuguesa
30409984 Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomics. John SE et al. 2018 Scientific reports
30425908 ADRB2 Gene Polymorphisms and Salbutamol Responsiveness in Serbian Children with Asthma. Jovicic N et al. 2018 Balkan journal of medical genetics
30468638 Beta(2)-adrenergic receptor variants in children and adolescents with bronchial asthma. Toraih EA et al. 2019 Frontiers in bioscience (Elite edition)
30485313 The magnitude of Yo-Yo test improvements following an aerobic training intervention are associated with total genotype score. Pickering C et al. 2018 PloS one
30542705 β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms. Xie WY et al. 2019 Oncology reports
30568487 A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer. Du Y et al. 2018 Breast cancer (Dove Medical Press)
30668166 β(2)-Adrenergic Receptor Gene Polymorphisms Are Associated with Cardiovascular Events But not All-Cause Mortality in Coronary Artery Disease Patients: A Meta-Analysis of Prospective Studies. Li Y et al. 2019 Genetic testing and molecular biomarkers
30774389 Association of genetic variants with level of asthma control in the Arab population. Almomani BA et al. 2019 Journal of asthma and allergy
30837870 Beta2-Adrenergic Receptor Polymorphisms and Haplotypes Associate With Chronic Pain in Sickle Cell Disease. Jhun EH et al. 2019 Frontiers in pharmacology
30972198 Single nucleotide polymorphisms of let-7-related genes increase susceptibility to breast cancer. Du Y et al. 2019 American journal of translational research
31007954 Association of ADRB2 rs1042713 with Obesity and Obesity-Related Phenotypes and Its Interaction with Dietary Fat in Modulating Glycaemic Indices in Malaysian Adults. Mitra SR et al. 2019 Journal of nutrition and metabolism
31056593 POLYMORPHISMS IN β-ADRENERGIC RECEPTORS ARE ASSOCIATED WITH INCREASED RISK TO HAVE A POSITIVE HEAD-UP TILT TABLE TEST IN PATIENTS WITH VASOVAGAL SYNCOPE. Márquez MF et al. 2019 Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
31090079 β(2) -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies. Shahin MH et al. 2019 Journal of clinical pharmacology
31129315 Systematic Review and Meta-Analysis of Genetic Risk of Developing Chronic Postsurgical Pain. Chidambaran V et al. 2020 The journal of pain
31264537 Polymorphisms in COMT, ADRB2 and HTR1A genes are associated with temporomandibular disorders in individuals with other arthralgias. Bonato LL et al. 2021 Cranio
31285095 Evaluation of genetic risk related to catechol-O-methyltransferase (COMT) and β2-adrenergic receptor (ADRB2) activity in different diagnostic subgroups of temporomandibular disorder in Brazilian patients. de Souza Tesch R et al. 2020 International journal of oral and maxillofacial surgery
31343553 A Genome-Wide Association Study of Sprint Performance in Elite Youth Football Players. Pickering C et al. 2019 Journal of strength and conditioning research
31455332 Dissecting genetic factors affecting phenylephrine infusion rates during anesthesia: a genome-wide association study employing EHR data. Zhang Y et al. 2019 BMC medicine
31481635 β(2)-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort study. Ingebrigtsen TS et al. 2019 Thorax
31538939 The Influence of Beta-2 Adrenergic Receptor Gene Polymorphisms on Albuterol Therapy for Patients With Asthma: Protocol for a Systematic Review and Meta-Analysis. Hikino K et al. 2019 JMIR research protocols
31683975 β(2)-Adrenergic Receptor (ADRB2) Gene Polymorphisms and Risk of COPD Exacerbations: The Rotterdam Study. Karimi L et al. 2019 Journal of clinical medicine
31699066 Association of β2-adrenergic receptor gene polymorphisms (rs1042713, rs1042714, rs1042711) with asthma risk: a systematic review and updated meta-analysis. Zhao S et al. 2019 BMC pulmonary medicine
31949291 Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation. King C et al. 2020 The pharmacogenomics journal
32101872 The Combined Effect of Polygenic Risk from FTO and ADRB2 Gene Variants, Odds of Obesity, and Post-Hipcref Diet Differences. Tan PY et al. 2020 Lifestyle genomics
32213001 UEG Week 2019 Poster Presentations. 2019 United European gastroenterology journal
32459809 Unique insights from ClinicalTrials.gov by mining protein mutations and RSids in addition to applying the Human Phenotype Ontology. Alag S et al. 2020 PloS one
32918113 Influence of rs1042713 and rs1042714 polymorphisms of β2-adrenergic receptor gene with erythrocyte cAMP in sickle cell disease patients from Odisha State, India. Sinha S et al. 2020 Annals of hematology
33170161 Genetic test for the prescription of diets in support of physical activity. Naureen Z et al. 2020 Acta bio-medica
33277970 Association of a four-gene model with allergic diseases: Two-year follow-up of a birth cohort study. Hua L et al. 2021 Immunity, inflammation and disease
33451866 Influence of ADRB1, ADRB2, and COMT Genetic Polymorphisms on Postoperative Outcomes of Patients Undergoing Cardiac Valve Surgery. Dai S et al. 2021 Clinical therapeutics
33458655 Comparison of Beta-2 Adrenergic Receptor Gene Polymorphisms Between Patients with Fibromyalgia Syndrome and Healthy Controls. Şen ÇakiroĞlu G et al. 2020 Archives of rheumatology
33479111 Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents. Ruffles T et al. 2021 The European respiratory journal
33519226 Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon. Fernandes MR et al. 2021 Pharmacogenomics and personalized medicine
33546600 Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management. Ledergerber M et al. 2021 BMC gastroenterology
33584143 Influence of b2 adrenergic receptor polymorphism (rs1042713 and rs1042714) on anthropometric, hormonal and lipid profiles in polycystic ovarian syndrome. Daghestani MH et al. 2021 Journal of medical biochemistry
33659822 The role of polymorphic variants of arginase genes (ARG1, ARG2) involved in beta-2-agonist metabolism in the development and course of asthma. Savelieva ON et al. 2020 Vavilovskii zhurnal genetiki i selektsii
33706416 Genome-wide association studies of exacerbations in children using long-acting beta2-agonists. Slob EMA et al. 2021 Pediatric allergy and immunology
34090290 ARG16GLY POLYMORPHISM IN THE β2-ADRENOCEPTOR GENE IN PATIENTS WITH BRONCHIAL ASTHMA. Kachkovska VV et al. 2021 Wiadomosci lekarskie (Warsaw, Poland
34131278 Genetic polymorphisms associated with obesity in the Arab world: a systematic review. Younes S et al. 2021 International journal of obesity (2005)
34243801 Gene-gene and gene-environment interactions on cord blood total IgE in Chinese Han children. Hua L et al. 2021 Allergy, asthma, and clinical immunology
34440404 Genetic Profile in Genes Associated with Cardiorespiratory Fitness in Elite Spanish Male Endurance Athletes. Varillas-Delgado D et al. 2021 Genes
34638656 Towards Understanding the Genetic Nature of Vasovagal Syncope. Matveeva N et al. 2021 International journal of molecular sciences
34713976 β1-receptor polymorphisms and junctional ectopic tachycardia in children after cardiac surgery. Dumeny L et al. 2022 Clinical and translational science
35044333 Single-nucleotide polymorphism of ADRβ2 and CDKN1B genes in Egyptian patients with coronary artery in-stent restenosis. Abdelaziz TA et al. 2022 Coronary artery disease
35099251 Beta-adrenergic receptors gene polymorphisms are associated with cardiac contractility and blood pressure variability. Matuskova L et al. 2021 Physiological research
35199539 Adrenergic receptors gene polymorphisms and autonomic nervous control of heart and vascular tone. Matušková L et al. 2021 Physiological research
35258481 Genetic biomarkers of life-threatening pheochromocytoma-induced cardiomyopathy. Amar J et al. 2022 Endocrine-related cancer
35308505 Vitamin D Supplementation and Genetic Polymorphisms Impact on Weight Loss Diet Outcomes in Caucasians: A Randomized Double-Blind Placebo-Controlled Clinical Study. Xenos K et al. 2022 Frontiers in medicine
35743738 Pharmacogenomic Profile of Amazonian Amerindians. Rodrigues JCG et al. 2022 Journal of personalized medicine
36011305 Single Nucleotide Polymorphisms in Amlodipine-Associated Genes and Their Correlation with Blood Pressure Control among South African Adults with Hypertension. Masilela C et al. 2022 Genes
36111412 Clinical course of COPD in patients with Arg16Gly (rs1042713) polymorphism of <em>ADRB2</em> gene. Dmytriiev K et al. 2022 Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace
36164570 Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard. Alshabeeb MA et al. 2022 Saudi pharmaceutical journal
36206635 Dietary protein interacts with polygenic risk scores and modulates serum concentrations of C-reactive protein in overweight and obese Malaysian adults. Tan PY et al. 2022 Nutrition research (New York, N.Y.)
36479490 Clinical assessment for diet prescription. Kiani AK et al. 2022 Journal of preventive medicine and hygiene
36776603 Interactions between genetic and lifestyle factors on cardiometabolic disease-related outcomes in Latin American and Caribbean populations: A systematic review. Wuni R et al. 2023 Frontiers in nutrition
37228580 Immunogenetics and pharmacogenetics of allergic asthma in Africa. Mabelane T et al. 2023 Frontiers in allergy
37851445 Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis. Kirkham JK et al. 2023 JAMA network open
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post825+45319f0